Group Percent of graft cells that co-labeled for these markers (mean% ± SD)
Nestin MAP2 GFAP KI67
Injection 74% (± 38) 19% (± 40) 0% 18% (± 17)
Injection+oral 56% (± 43) 12% (± 20) 0% 18% (± 11)
Oral 87% 0% 0% 23%
Control 48% (± 50) 0% 0% 9% (± 8)
Table 2: Graft cell differentiation.